|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
25
|
|
pubmed:dateCreated |
2003-12-18
|
|
pubmed:abstractText |
Benign prostatic hyperplasia is commonly treated with alpha-adrenergic-receptor antagonists (alpha-blockers) or 5alpha-reductase inhibitors. The long-term effect of these drugs, singly or combined, on the risk of clinical progression is unknown.
|
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/U01 DK-49880,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK-49960,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK41418,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK46416,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK46429,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK46431,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK46437,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK46468,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK46472,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK49912,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK49951,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK49954,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK49963,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK49964,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK49971,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK49977,
http://linkedlifedata.com/resource/pubmed/grant/U01 DK49980
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
pubmed-author:AndrioleGerald LGLJr,
pubmed-author:BautistaOliver MOM,
pubmed-author:ClarkeHarry SHS,
pubmed-author:CrawfordE DavidED,
pubmed-author:DioknoAnaniasA,
pubmed-author:DixonChristopher MCM,
pubmed-author:FoleyJohn PJP,
pubmed-author:FosterHarris EHE,
pubmed-author:JacobsStephen CSC,
pubmed-author:KaplanSteven ASA,
pubmed-author:KrederKarl JKJ,
pubmed-author:KusekJohn WJW,
pubmed-author:LeporHerbertH,
pubmed-author:LieberMichael MMM,
pubmed-author:LuciaM ScottMS,
pubmed-author:McConnellJohn DJD,
pubmed-author:McVaryKevin TKT,
pubmed-author:Medical Therapy of Prostatic Symptoms (MTOPS) Research Group,
pubmed-author:MenonManiM,
pubmed-author:MilamDouglas FDF,
pubmed-author:MillerGary JGJ,
pubmed-author:NybergLeroy MLMJr,
pubmed-author:RamsdellJoe WJW,
pubmed-author:RoehrbornClaus GCG,
pubmed-author:SchenkmanNoah SNS,
pubmed-author:SlawinKevin MKM,
pubmed-author:SmithJoseph AJA
|
|
pubmed:copyrightInfo |
Copyright 2003 Massachusetts Medical Society
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
18
|
|
pubmed:volume |
349
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2387-98
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:14681504-5-alpha Reductase Inhibitors,
pubmed-meshheading:14681504-Adrenergic alpha-Antagonists,
pubmed-meshheading:14681504-Analysis of Variance,
pubmed-meshheading:14681504-Disease Progression,
pubmed-meshheading:14681504-Double-Blind Method,
pubmed-meshheading:14681504-Doxazosin,
pubmed-meshheading:14681504-Drug Therapy, Combination,
pubmed-meshheading:14681504-Enzyme Inhibitors,
pubmed-meshheading:14681504-Finasteride,
pubmed-meshheading:14681504-Humans,
pubmed-meshheading:14681504-Male,
pubmed-meshheading:14681504-Middle Aged,
pubmed-meshheading:14681504-Prostatic Hyperplasia,
pubmed-meshheading:14681504-Severity of Illness Index
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.
|
|
pubmed:affiliation |
University of Texas Southwestern Medical Center, Dallas, TX 75390-9110, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.
|
